Log In
Print this Print this

Antineoplastons (ANP) therapy

  Manage Alerts
Collapse Summary General Information
Company Burzynski Research Institute Inc.
DescriptionCombination of Atengenal (antineoplaston A10) and Astugenal (antineoplaston AS2-1)
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationBrain cancer
Indication DetailsTreat advanced non-operable brainstem glioma (BSG); Treat anaplastic astrocytoma; Treat diffuse, intrinsic brainstem glioma in pediatric patients; Treat glioma; Treat optic pathway glioma (OPG) in pediatric patients
Regulatory Designation


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today